Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 10, 2011 | Ambit Pharmaceuticals | $30.0M Series D | Allan Marchington | Forward Ventures, Gimv, GrowthWorks, Horizon Technology Finance, MedImmune Ventures, NovaQuest Capital Management, OrbiMed, Perseus-Soros Biopharmaceutical Fund, Radius Ventures, Roche |
| Nov 1, 2007 | Ambit Biosciences | $49.0M Series D | — | OrbiMed, Allan Marchington, Avalon Ventures, Standish Fleming, Gimv, Horizon Technology Finance, Jov-CMDF, David Mott, NovaQuest Capital Management, Perseus-Soros Biopharmaceutical Fund, Radius Ventures, Roche |
| Mar 15, 2002 | PhageTech | $10.1M Other Equity | CDP Capital Technology Ventures | MDS Capital, Seaflower Ventures, T2C2/Bio |